Similar results were reported for nasopharyngeal cancer cells, albeit with a less well defined AKT-inhibitory reagent, DC120, that blocks AKT in its Thr308 and Ser473 phosphorylated state [94]. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.